Any effects of SGLT2 inhibitors on iron metabolism in CKD would be important to understand, given the high prevalence of iron deficiency and anemia in this population, especially as kidney function declines [3, 15]. This evidence concerns the gene SLC5A2 and Iron deficiency anemia.